Filing Details

Accession Number:
0001123292-21-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-04 17:10:07
Reporting Period:
2020-12-30
Accepted Time:
2021-01-04 17:10:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882104 Pdl Biopharma Inc. PDLI Biological Products, (No Disgnostic Substances) (2836) 943023969
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1029625 A Edward Mule Two Greenwich Plaza, First Floor
Greenwich CT 06830
No No Yes No
1332784 L.p. Capital Point Silver Two Greenwich Plaza, First Floor
Greenwich CT 06830
No No Yes No
1382617 J Robert O'shea Two Greenwich Plaza, First Floor
Greenwich CT 06830
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-30 6,325,213 $2.50 23,783,273 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Silver Point Capital, L.P. ("Silver Point") or its wholly owned subsidiaries are the investment managers of Silver Point Capital Fund, L.P., Silver Point Capital Offshore Master Fund, L.P., Silver Point Distressed Opportunities Fund, L.P., Silver Point Distressed Opportunities Offshore Master Fund, L.P., Silver Point Distressed Opportunity Institutional Partners, L.P. and Silver Point Distressed Opportunity Institutional Partners Master Fund (Offshore), L.P. (the "Funds") and, by reason of such status, may be deemed to be the beneficial owner of all of the reported securities held by the Funds. Silver Point Capital Management, LLC ("Management") is the general partner of Silver Point and as a result may be deemed to be the beneficial owner of all securities held by the Funds. Messrs. Edward A. Mule and Robert J. O'Shea are each members of Management and as a result may be deemed to be the beneficial owner of all of the securities held by the Funds. Silver Point, Management and Messrs. Mule and O'Shea disclaim beneficial ownership of the reported securities held by the Funds except to the extent of their pecuniary interests.